Hanan Ben-Asher, COO and Business Development at PixCell Medical discusses the development of a novel miniaturized portable hematology analyzer called HemoScreen™, which provides diagnostic results in minutes instead of days. With just one drop of blood and within six minutes, HemoScreen delivers accurate readings of 20 standard blood count parameters, saving patients, clinicians and health systems time and money. He also talks about the benefits of using AI in diagnostics, how diagnostic technologies played a major role in battling COVID-19, and how point of care testing is the future of disease maintenance.
Hanan Ben-Asher is an experienced business executive with expertise in multidisciplinary research and development with a strong background in medical device development. Prior to his position at PixCell, Hanan served as R&D manager at Medoc Advanced Medical Systems. He holds a B.Sc. (cum laude) in Biomedical Engineering and an MBA, both from the Technion Israel Institute of Technology.